#United States #Milwaukee #Pregnancy #Beta-Lactam Allergy #Penicillin

Evaluating Beta-Lactam Allergy Delabeling in Pregnant Patients

Recent research presented at the 2026 AAAAI Annual Meeting indicates that assessing penicillin allergies and subsequently delabeling them may significantly reduce the unnecessary use of alternative antibiotics among pregnant patients, particularly those who test positive for group B streptococcus (GBS). Conducted by leading allergists, the study aims to emphasize the safety of penicillin evaluation during pregnancy and its potential impact on maternal and neonatal health.

Background on Penicillin Allergy in Pregnancy

Pregnant women often face challenges regarding antibiotic administration, particularly when labeled with a penicillin allergy. The widespread use of beta-lactam antibiotics is crucial for treating various infections during pregnancy. However, many patients are unnecessarily labeled as allergic to penicillin due to historical misdiagnoses. This can lead to the increased use of alternative antibiotics, which may not only be less effective but also carry higher risks of adverse outcomes.

Dr. Divya L. Jasthi, the primary author of the study, underscores the necessity of critically evaluating allergy testing methods in pregnancy. She notes, "Beta-lactam allergy labels in pregnancy lead to alternative antibiotic use associated with increased risk of adverse outcomes. Evaluating beta-lactam allergy in pregnant patients can potentially reduce this tendency."

Study Overview

The research was conducted as a single-center retrospective study analyzing third-trimester pregnant patients referred for penicillin allergy testing between June 2023 and August 2025. Researchers utilized both descriptive analysis and chi-squared analysis methods to evaluate the association between beta-lactam allergy testing and subsequent antibiotic use.

Among the 111 pregnant patients referred for penicillin evaluation, 58 underwent testing. The testing included 10/90 challenges and skin testing, followed by full-dose challenges. Remarkably, only one patient showed a positive skin test, while two had reactions to an amoxicillin challenge despite negative skin tests. This indicates that the predictive power of skin testing may be limited for certain individuals.

Key Findings

From the 71 deliveries in the study, 35 patients out of the 58 completed penicillin evaluations. Notably, among the 13 GBS-positive patients, only eight received penicillin allergy evaluations, resulting in five being left unevaluated. Alarmingly, three of those who did not complete the evaluation were administered alternative beta-lactam antibiotics during delivery. The study found a significant association between the lack of allergy evaluation and the receipt of alternative antibiotics among GBS-positive patients, with a statistical significance of (X2 = 6.24, p = 0.0125).

This finding raises substantial concerns regarding patient care practices in obstetrics and suggests that enhanced alpha testing protocols may be needed to ensure optimal maternal and fetal health outcomes.

Recommendations for Future Practice

The researchers recommend that direct oral challenges be prioritized over traditional skin testing methods, particularly considering the inconsistency in reactions noted among study participants. They also advocate for further investigations into the outcomes associated with various testing methodologies to better inform clinical practices and improve patient safety.

Future research should focus on establishing standardized testing protocols tailored for pregnant patients, which would contribute to advancing patient care and minimizing reliance on less effective alternative antibiotics.

For more information on the implications of this research and to stay updated on developments in allergy science, visit aaaai.org.

Conclusion

The exploration of beta-lactam allergy delabeling among pregnant patients marks a significant step toward refining treatment protocols that ensure safety and efficacy. With findings from this research, health professionals are called to reconsider standard practices and advocate for improved patient outcomes through careful allergy evaluation.

As the American Academy of Allergy, Asthma & Immunology continues to lead discussions in this area, the overarching goal remains clear: to enhance the safety and quality of care for expecting mothers.